Policy and implementation resources for women's health
Evidence-based policy and health system frameworks are essential to improving outcomes for women with thrombosis and hemostasis disorders worldwide. This hub provides policymakers and healthcare leaders with ISTH policy statements, World Health Organization guidelines, health system implementation tools, budget impact analyses and international case studies. These resources support the development of national strategies, funding proposals and clinical service frameworks that address the unique challenges of bleeding and clotting disorders across women's reproductive lifespan.
Policy
Resources
World Health Organization (WHO) Women’s Health
Women in Global Health (WGH)
Organisation for Economic Co-operation and Development (OECD) Gendered Differences in Health Outcomes and Healthcare Access
ISTH policy statements
ISTH policy statements and public affairs resources support evidence-informed approaches to improving awareness, access to care and patient safety in bleeding and clotting disorders. These resources help advance dialogue with policymakers, strengthen health systems and promote practical solutions to address disparities affecting women across the lifespan.
​
WHO guidelines and framework
The WHO provides guidance to support women’s health across the life course, emphasizing gender-responsive care, health equity and stronger health systems. These resources can help inform policy, improve quality of care and support safer, more individualized approaches to prevention, diagnosis and treatment, including areas relevant to bleeding and clotting disorders in women.
Advocacy toolkit for women’s bleeding and clotting health
Download a practical toolkit designed to support advocacy, inform policy discussions and advance action to improve care for women across the bleeding and clotting spectrum. This resource includes key messages, policy considerations and tools to help address disparities, strengthen health systems and support evidence-based solutions.
.png)
Integrate women’s blood health across the life course
Policies should recognize that bleeding and clotting disorders affect women differently across adolescence, reproductive years, pregnancy, postpartum and menopause. National health strategies should incorporate risk assessment, prevention and management approaches that protect women at every life stage.
Strengthen patient safety through earlier recognition and standardized care
Missed diagnoses and inconsistent care pathways can lead to preventable harm. Policies should support standardized protocols, provider training and integrated care pathways to improve early recognition, patient safety and outcomes for women with bleeding and clotting disorders.
Expand equitable access to diagnosis, medicines and specialized care
Women cannot benefit from care they cannot access. Ministries of Health can help reduce disparities by improving access to diagnostics, essential medicines, trained providers and referral networks, including in underserved and low-resource settings.
Invest in research, data and inclusion in women’s health policies
Women with bleeding and clotting disorders, including venous thromboembolism, von Willebrand disease and pregnancy-related hemostatic complications, remain underrepresented in clinical research and health policy, making targeted investment in sex-disaggregated data, inclusive trial design and women-centered health policies essential to closing the diagnosis and treatment gap.
